Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer

Yalcin, ŞUAYİB; Oksuzoglu, B; Tekuzman, G; Engin, H; Celik, İSMAİL; Turker, A; Barista, İBRAHİM; Gullu, İBRAHİM; Guler, N; Altundag, K; Ozisik, Y; Kars, A

doi:10.1093/jjco/hyg111

Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer

Atıf İçin Kopyala

Yalcin S. , Oksuzoglu B., Tekuzman G., Engin H., Celik I. , Turker A., ...Daha Fazla

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, cilt.33, ss.580-583, 2003 (SCI İndekslerine Giren Dergi)

Cilt numarası: 33 Konu: 11
Basım Tarihi: 2003
Doi Numarası: 10.1093/jjco/hyg111
Dergi Adı: JAPANESE JOURNAL OF CLINICAL ONCOLOGY
Sayfa Sayıları: ss.580-583

Özet

Objective: In this study, we evaluated the efficacy and tolerability of biweekly irinotecan (CPT-11) plus 5-fluorouracil (5-FU) and folinic acid (FA) regimen (IFL) in patients with advanced stage colorectal cancer.